share_log

Larimar Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Apr 11, 2020 04:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more